As cancer patients are living longer and the number of cancer survivors increases, more secondary complications related to cancer and its treatments are being recognized. A large number of neuromuscular processes, stemming from cancer itself, from secondary metabolic effects, from paraneoplastic syndromes, from preexisting conditions, or from adverse effects related to cancer treatments, can affect the peripheral nervous system at any level. Electrodiagnostic tools such as nerve conduction studies and needle electromyography are uniquely suited to assess the function of the peripheral nervous system and are valuable tools in confirming and defining neuromuscular dysfunction and in helping guide oncologic and physiatric treatment and prognosis for the cancer rehabilitation patient.
From the Rehabilitation Medicine Service, Department of Neurology, Memorial Sloan-Kettering Cancer Center, and Department of Rehabilitation Medicine, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York.
All correspondence and requests for reprints should be addressed to: Christian M. Custodio, MD, Memorial Sloan-Kettering Cancer Center Outpatient Rehabilitation Center, 515 Madison Avenue, 5th Floor, New York, NY 10022.
Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.